Artikel
Non-invasive screening for acute rejection in murine renal transplantation using MR renography and diffusion weighted MRI
Suche in Medline nach
Autoren
Veröffentlicht: | 21. März 2014 |
---|
Gliederung
Text
Introduction: Biopsies are often required to detect the underlying condition for deterioration of the transplant function. Here, we tested a novel substance which inhibits the MCP1/CCR2 pathway via oligonucleotides in a murine renal Tx model. The aim was 1.) to detect potential effects of this drug on acute rejection processes and 2.) show that MR-renography in combination with diffusion weighted imaging (DWI) may be a valuable new tool to non-invasively monitor these rejection processes.
Material and methods: Kidneys of Balb/c mice were transplanted onto B6. Mice were either treated with the anti-MCP1-Spiegelmer in monotherapy or in combination with subtherapeutic CsA (10mg/kgBW). For further analysis immunohistochemistry, doppler ultrasound, MR-renography and diffusion-weighted MRI were used.
Results: The number of F4/80+ cells was efficiently suppressed and kidney cortex perfusion measurements improved under combination therapy. The apparent diffusion coefficient (ADC) of native kidneys and syngenic allografts did not show significant differences. Allogenic allografts without treatment showed significantly lower ADC (p<0.001). Under combination therapy the ADC significantly improved (p=0.002).
Conclusion: The novel drug based on oligonucleotide technology inhibiting the MCP1 alleviates acute rejection. Diffusion-weighted MRI in combination with MR-renography may serve as a valuable tool to detect rejection processes.